Abstract Microbes produce an extraordinary array of microbial defense systems.
INTRODUCTION

What Are Microbial Defense Systems?
Microbes produce an extraordinary array of microbial defense systems. These include broad-spectrum classical antibiotics so critical to human health concerns, metabolic by-products such as the lactic acids produced by lactobacilli, lytic agents such as lysozymes found in many foods, numerous types of protein exotoxins, and bacteriocins, which are loosely defined as biologically active protein moieties with a bacteriocidal mode of action (41, 90) . This biological arsenal is striking not only in its diversity but in its natural abundance. For instance lactic acid production is a defining trait of lactic acid bacteria (36) . Bacteriocins are found in almost every bacterial species examined to date, and within a species tens or even hundreds of different kinds of bacteriocins are produced (41, 72) . Halobacteria universally produce their own version of bacteriocins, the halocins (95) . Streptomycetes commonly produce broad-spectrum antibiotics (79) . It is clear that microbes invest considerable energy into the production and elaboration of antimicrobial mechanisms. Less clear is how such diversity arose and what roles these biological weapons serve in microbial communities.
One family of microbial defense systems, the bacteriocins, has served as a model for exploring evolutionary and ecological questions. In this review, current knowledge of how the extraordinary range of bacteriocin diversity arose and is maintained in microbial populations is assessed, and the role these toxins play in mediating microbial dynamics is discussed. Fascination with bacteriocins is not restricted to the evolutionary and ecologically minded; in the latter half of this review our attention focuses on the potential application of these toxins to address human health concerns and the current and growing use of bacteriocins to aid in food preservation.
BACTERIOCINS: THE MICROBIAL WEAPON OF CHOICE
Bacteriocins differ from traditional antibiotics in one critical way: They have a relatively narrow killing spectrum and are only toxic to bacteria closely related to the producing strain. These toxins have been found in all major lineages of Bacteria and, more recently, have been described as universally produced by some members of the Archaea (95) . According to Klaenhammer, 99% of all bacteria may make at least one bacteriocin and the only reason we haven't isolated more is that few researchers have looked for them (47, 67) .
Bacteriocins of Gram-Negative Bacteria
The bacteriocin family includes a diversity of proteins in terms of size, microbial targets, modes of action, and immunity mechanisms. The most extensively studied, EVOLUTION 
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the colicins produced by Escherichia coli, share certain key characteristics (3, 6, 13, 30, 40, 48, 64) . Colicin gene clusters are encoded on plasmids and are composed of a colicin gene, which encodes the toxin; an immunity gene, which encodes a protein conferring specific immunity to the producer cell by binding to and inactivating the toxin protein; and a lysis gene, which encodes a protein involved in colicin release through lysis of the producer cell. Colicin production is mediated by the SOS regulon and is therefore principally produced under times of stress. Toxin production is lethal for the producing cell and any neighboring cells recognized by that colicin. A receptor domain in the colicin protein that binds a specific cell surface receptor determines target recognition. This mode of targeting results in the relatively narrow phylogenetic killing range often cited for bacteriocins. The killing functions range from pore formation in the cell membrane to nuclease activity against DNA, rRNA, and tRNA targets. Colicins, indeed all bacteriocins produced by gram-negative bacteria, are large proteins. Pore-forming colicins range in size from 449 to 629 amino acids. Nuclease bacteriocins have an even broader size range, from 178 to 777 amino acids.
Although colicins are representative of gram-negative bacteriocins, there are intriguing differences found within this subgroup of the bacteriocin family. E. coli encodes its colicins exclusively on plasmid replicons (65) . The nuclease pyocins of Pseudomonas aeruginosa, which show sequence similarity to colicins and other, as yet uncharacterized, bacteriocins are found exclusively on the chromosome (81) . Another close relative to the colicin family, the bacteriocins of Serratia marcesens, are found on both plasmids and chromosomes (20, 26, 32) .
Many bacteriocins isolated from gram-negative bacteria appear to have been created by recombination between existing bacteriocins (6, 51, 68, 76) . Such frequent recombination is facilitated by the domain structure of bacteriocin proteins. In colicins, the central domain comprises about 50% of the protein and is involved in the recognition of specific cell surface receptors. The N-terminal domain (∼25% of the protein) is responsible for translocation of the protein into the target cell. The remainder of the protein houses the killing domain and the immunity region, which is a short sequence involved in immunity protein binding. Although the pyocins produced by P. aeruginosa share a similar domain structure, the order of the translocation and receptor recognition domains are switched (80) . As we explore further below, the conserved domain configuration of these toxins is responsible for much of the bacteriocin diversity we find in nature.
Bacteriocins of Gram-Positive Bacteria
Bacteriocins of gram-positive bacteria are as abundant and even more diverse as those found in gram-negative bacteria (39, 90) . They differ from gram-negative bacteriocins in two fundamental ways. First, bacteriocin production is not necessarily the lethal event it is for gram-negative bacteria. This critical difference is due to the transport mechanisms gram-positive bacteria encode to release bacteriocin toxin. Some have evolved a bacteriocin-specific transport system, whereas others employ the sec-dependent export pathway. In addition, the gram-positive bacteria have evolved bacteriocin-specific regulation, whereas bacteriocins of gram-negative bacteria rely solely on host regulatory networks.
The lactic acid bacteria (LAB) are particularly prolific in bacteriocin production. Klaenhammer distinguishes three classes of LAB bacteriocins (47) . Class I bacteriocins are the lantibiotics, so named because they are post-translationally modified to contain amino acids such as lanthionine and B-methyllanthionine, and several dehydrated amino acids (33) . Lantibiotics are further divided into two subgroups, A and B, based on structural features and their mode of killing (43) . Type A lantibiotics kill the target cell by depolarizing the cytoplasmic membrane (2, 84) . They are larger than type B lantibiotics and range in size from 21 to 38 amino acids. Nisin, the archetypal and best-studied gram-positive bacteriocin, is a type A lantibiotic (31) . The type B lantibiotics have a more globular secondary structure and are smaller than type A, with none exceeding 19 amino acids in length. Type B lantibiotics function through enzyme inhibition. One example is mersacidin, which interferes with cell wall biosynthesis (7) .
Class II LAB bacteriocins are also small, ranging in size from 30 to 60 amino acids, and are heat-stable, nonlanthionine-containing peptides (43) . They are organized into subgroups: Class IIa is the largest group and its members are distinguished by a conserved amino-terminal sequence (YGNGVXaaC) and a shared activity against Listeria. Like type A lantibiotics, class IIa bacteriocins act through the formation of pores in the cytoplasmic membrane. Examples include pediocin AcH (4), sakacin A (83), and leucocin A (35) . Class IIb bacteriocins such as lacticin F (58) and lactococcin G (60) form pores composed of two different proteins in the membrane of their target cells. A third subgroup (IIc) has been proposed, which consists of bacteriocins that are sec-dependent (such as acidocin B) (52) . Class III bacteriocins are large heat-labile proteins such as helveticins J and V (42, 98) and lactacin B (1). An additional proposed class (VI) requires lipid or carbohydrate moieties for activity. Little is known about the structure and function of this proposed class. Examples include leuconocin S (8) and lactocin 27 (96) .
Gram-positive bacteriocins in general and lantibiotics in particular require many more genes for their production than do gram-negative bacteriocins. The nisin gene cluster includes genes for the prepeptide (nisA), enzymes for modifying amino acids (nisB, nisC), cleavage of the leader peptide (nisP), secretion (nisT ), immunity (nisI, nisFEG), and regulation of expression (nisR, nisK ) (9, 21, 22, 44, 50, 66, 97) . These gene clusters are most often encoded on plasmids but are occasionally found on the chromosome. Several gram-positive bacteriocins, including nisin, are located on transposons (18) .
The conventional wisdom about the killing range of gram-positive bacteriocins is that they are restricted to killing other gram-positive bacteria. The range of killing can vary significantly, from relatively narrow as in the case of lactococcins A, B, and M, which have been found to kill only Lactococcus (77) (57) . Contrary to conventional wisdom, these particular bacteriocins are also active against a number of medically important gram-negative bacteria including Campylobacter, Haemophilus, Helicobacter, and Neisseria (57) .
Production of bacteriocins in gram-positive bacteria is generally associated with the shift from log phase to stationary phase. Nisin production begins during mid-log phase and increases to a maximum as the cells enter stationary phase (9) . The regulation of expression is not cell cycle-dependent per se, but rather culture densitydependent. It has been demonstrated that nisin A acts as a protein pheromone in regulating its own expression, which is controlled by a two-component signal transduction system typical of many quorum-sensing systems. The genes involved are nisR (the response regulator) and nisK (the sensor kinase) (16) . Nisin transcription can be induced by the addition of nisin to the culture medium with the level of induction directly related to the level of nisin added (49, 50) .
Bacteriocins of Archaea
The Archaea produce their own distinct family of bacteriocin-like antimicrobials, known as archaeocins. The only characterized member is the halocin family produced by halobacteria, and few halocins have been described in detail (11, 75, 85) . The first halocin discovered, S8, is a short hydrophobic peptide of 36 amino acids, which is processed from a much larger pro-protein of 34 kD (63) . Halocin S8 is encoded on a megaplasmid and is extremely hardy; it can be desalted, boiled, subjected to organic solvents, and stored at 4
• C for extended periods without losing activity. Expression is growth stage-dependent. Although basal levels are present in low concentrations during exponential growth, there is an explosive ninefold increase in production during the transition to stationary phase (85) . The mechanism of halocin action has been established only for halocin H6 (a Na+/H+ antiporter inhibitor), and the immunity mechanism is unknown (94) .
Archaeocins are produced as the cells enter stationary phase. When resources are limited, producing cells lyse sensitive cells and enrich the nutrient content of the local environment. As stable proteins, they may remain in the environment long enough to reduce competition during subsequent phases of nutrient flux. The stability of halocins may help explain why there is so little species diversity in the hypersaline environments frequented by halobacteria (85) .
As is clear from this brief survey of bacteriocin diversity and distribution, this heterogeneous family of toxins is united only by the shared features of being protein-based toxins that are relatively narrow in killing spectrum and often extremely hardy and stable. What makes these the weapons of choice in the microbial world remains an intriguing question.
EVOLUTION OF BACTERIOCIN DIVERSITY
Colicins as a Model for Evolutionary Studies
The colicins and other enteric bacteriocins, such as klebicins, remain the only bacteriocins for which detailed evolutionary investigations have been undertaken. Among the colicins, there are two main evolutionary lineages, which also distinguish the two primary modes of killing: pore formation and nuclease activity (70) . Studies that include DNA and protein sequence comparisons (6, 68) , surveys of DNA sequence polymorphism in natural isolates (62, 74, 92) , experimental evolution (28, 91) , and mathematical modeling (28) have revealed two primary modes of colicin evolution (93) .
The Role of Diversifying Recombination in Colicin Evolution
The more abundant pore-former colicins are generated by domain shuffling, which is mediated by recombination (6, 93) . All characterized pore-former colicin proteins share one or more regions with high levels of sequence similarity to other pore-former colicins (Figure 1 ). This patchwork of shared and divergent sequences suggests frequent recombination. The location of the different patches frequently corresponds to the different functional domains of the proteins. The most recent illustration of the power of diversifying recombination is seen in the first published klebicin sequence (Figure 2 ), which is a nuclease klebicin that shares sequence similarity with both colicin A-like pore former and pyocin S1-like nuclease sequences (73) . Such domain-based shuffling between bacteriocins is responsible for much of the variability observed among gram-negative bacteriocins.
The influence of diversifying recombination is not limited to the closely related bacteriocins of enteric bacteria. As mentioned above, the S pyocins of P. aeruginosa are the result of recombination between several pore-former and nuclease colicins with other, as yet uncharacterized, bacteriocins (81, 82) . Even altering the domain structure of the protein, as seen for pyocins that have switched the receptor recognition and translocation domains relative to the order found in colicins, has not limited the influence of diversifying recombination.
The Role of Diversifying Selection in Colicin Evolution
An alternative mode of evolution is responsible for the current diversity of nuclease colicins. These colicins, which include both RNase-and DNase-killing functions, share a recent common ancestry. Their DNA sequences are quite similar, ranging from 50% to 97% sequence identity. However, many pairs of nuclease colicins have elevated levels of divergence in the immunity region ( Figure 3 ). To explain this pattern of divergence, Riley and collaborators have proposed a two-step process of mutation and selection (68, 69, 93) .
The diversifying selection hypothesis posits the action of strong positive selection acting on mutations that generate novel immunity and killing functions ( Figure 4 ). The first event in this process is the occurrence of a mutation in the immunity gene resulting in a broadened immunity function. The resulting producer cell is now immune to the ancestral version of the colicin as well as having gained immunity to some number of similar colicins. This broadened immunity function increases the fitness of the producer strain in populations where multiple colicins are found, which is the case in all E. coli populations sampled to date (29, 72) . A second mutation, this time in the colicin gene, is paired with the immunity mutation. This pair of mutations produces a novel colicin that is no longer recognized by the ancestral immunity protein. Thus, the possessor of the novel colicin will rapidly displace (by killing) the ancestral, formerly abundant bacteriocin-producing strain. This evolved colicin will ultimately be replaced by yet another novel colicin as the cycle repeats itself. This process results in a family of closely related proteins that have diverged most extensively in the region involved in immunity binding and killing function, as seen for nuclease colicins (69) .
Recently, the DNA sequence of a new pore-former colicin, Y, was determined (71) . Colicin Y is a close relative of colicin U, another pore-former colicin isolated from a different continent over 20 years earlier (86) . This pair of colicins has a pattern of DNA substitution identical to that observed among the nuclease colicins with an elevated level of substitution in the immunity region. This observation suggests that the process of diversifying selection is not restricted to nuclease colicins. Further, several E2 colicins isolated from Australia suggest that diversifying recombination is not restricted to pore-former colicins (92) . Half of the E2 producers carry the characterized E2 plasmid. The other half carry a recombinant plasmid with sequences derived from colicin E7 and the characterized E2 plasmid. These isolated observations suggest that it is not the case that pore formers diversify only by means of recombination and nuclease colicins by diversifying selection. The evolutionary process is more complex than the proposed simple dichotomy suggests.
Figure 4
The hypothesis of diversifying selection invokes two steps in the generation of a novel immunity function. (a) A point mutation in the immunity gene generates a broadened immunity function (noted with an asterisk). The strain with this colicin gene cluster is immune to itself, to its ancestor, and to other closely related colicins (noted with gray arrows). The ancestral colicin is immune to itself and to the evolved colicin (noted with black arrows). (b) A paired mutation occurs in the immunitybinding portion of the evolved colicin gene that generates a "super-killer" (noted with a second asterisk). The evolved strain is still immune to itself, its ancestor, and other colicins. However, the ancestral strain is now no longer immune to the evolved strain (noted with an X ).
A Two-Step Process of Colicin Evolution
Riley has developed a model of colicin diversification that involves two phases (70) . When rare, as is currently the case for most nuclease colicins, the occurrence of point mutations that alter immunity function may be the primary mode for generating novel bacteriocin phenotypes. Novel immunity and killing functions are rapidly selected since they allow a cell to avoid being killed by other bacteriocins or allow cells carrying them to displace their ancestors. These novel bacteriocins are then maintained until a new immunity or killing function emerges. When colicins are abundant, as is the case for many pore-former colicins, domain swapping may become a more frequent mode of diversification. This "switch" in evolutionary mechanism is due simply to the requirement for a set of bacteriocins to be abundant enough to serve as templates for recombination. Once abundant, recombination can more rapidly generate additional diversity. Finally, some new enteric bacteriocins have no similarity with those characterized previously. A particularly interesting example of this latter observation is the recently described Colicin Js (87) . This plasmid-borne bacteriocin has a typical colicin gene cluster composition, with toxin, immunity, and lysis genes. However, the organization of the gene cluster is unique in that the lysis gene is transcribed 5 to the toxin gene. The genes themselves show no similarity to any known bacteriocin genes, and the encoded toxin is 94 amino acids, which is smaller than any other described colicin.
Bacteriocin-encoding plasmids, such as pColJs (which encodes colicin Js) and pKlebB (which encodes klebicin B), demonstrate another aspect of bacteriocin evolution (73, 87) . These bacteriocin plasmids are chimeras with a plasmid "backbone" comprising replication and maintenance sequences typical of plasmids found in the bacteriocins' host species. In the case of pKlebB isolated from Klebsiella pneumoniae, the plasmid contains sequences similar to pNBL63 (102) and pJHC-MW1 (17), isolated from K. oxytoca and K. pneumoniae respectively, encoding plasmid maintenance functions. The sequence surrounding and comprising part of the klebicin B gene cluster shares similarity with colicin A and E9, originally isolated from E. coli (73) . In the case of pColJs, the plasmid backbone is virtually identical to ColE1, whereas the DNA flanking the colicin Js gene cluster shows high similarity to pPCP1 from Yersinia pestis (37) . The colicin Js gene cluster itself has a significantly lower G + C content (33.6%) than the rest of the plasmid (52.9%), indicating that it originated from yet a third source (87), perhaps even outside of the Enterobacteriaceae. This type of recombination, although not altering the bacteriocin genes proper, results in an increased host range. As we continue to explore bacteriocin diversity, our model of bacteriocin evolution will almost certainly become more elaborate and complex.
ECOLOGICAL ROLE OF BACTERIOCINS
Without question, bacteriocins serve some function in microbial communities. This statement follows from the detection of bacteriocin production in all surveyed lineages of prokaryotes. Equally compelling is the inference of strong positive selection acting on enteric bacteriocins. Such observations argue that these toxins play a critical role in mediating microbial population or community interactions. What remains in question is what, precisely, that role is.
Bacteriocins may serve as anti-competitors enabling the invasion of a strain into an established microbial community. They may also play a defensive role and act to prohibit the invasion of other strains or species into an occupied niche or limit the advance of neighboring cells. An additional role has recently been proposed for gram-positive bacteriocins, in which they mediate quorum sensing (55) . It is likely that whatever roles bacteriocins play, these roles change as components of the environment, both biotic and abiotic, change.
Theoretical and Experimental Studies of Bacteriocin Ecology
Early experimental studies on the ecological role of bacteriocins were inconclusive and contradictory (14, 24, 27, 34, 38, 45, 101) . More recently a theoretical and empirical base has been established that has defined the conditions that favor maintenance of toxin-producing bacteria in both population and community settings. Almost exclusively, these studies have modeled the action of colicins. Chao & Levin showed that the conditions for invasion of a colicin-producer strain were much broader in a spatially structured environment than in an unstructured one (10) . In an unstructured environment with mass-action, a small population of producers cannot invade an established population of sensitive cells. This failure occurs because the producers pay a price for toxin production-the energetic costs of plasmid carriage and lethality of production-but the benefits, the resources made available by killing sensitive organisms, are distributed at random. Moreover, when producers are rare, the reduction in growth rate experienced by the sensitive strain (owing to extra deaths) is smaller than the reduction felt by the producer (owing to its costs), and the producer population therefore becomes extinct. In a physically structured environment, such as on the surface of an agar plate, the strains grow as separate colonies. Toxin diffuses out from a colony of producers, thus killing sensitive neighbors. The resources made available accrue disproportionately to the producing colony owing to its proximity, and therefore killers can increase in frequency even when initially rare.
The Rock-Paper-Scissors Model
Recent modeling efforts have incorporated additional biological reality. Two such efforts introduced a third species, one that is resistant to the toxin but cannot itself produce the toxin (15, 46) . Resistance can be conferred through mutations in either the binding site or the translocation machinery required for a bacteriocin to enter the target cell. Acquisition of an immunity gene will also confer resistance to its cognate bacteriocin. The authors in both studies reasonably assume there is a cost to resistance and that this cost is less than the cost of toxin production borne by the killer strain (25) . Owing to this third member, pairwise interactions among the strains have the nontransitive structure of the childhood game of rock-paperscissors (Table 1) (53) . The producer strain beats the sensitive strain, owing to the toxin's effects on the latter. The sensitive strain beats the resistant strain because only the latter suffers the cost of resistance. And the resistant strain wins against the producer because the latter bears the higher cost of toxin production and release while the former pays only the cost of resistance. In an unstructured environment, this game allows periodic cycles, in which all three types coexist indefinitely but each with fluctuating abundance. In a structured environment, this game permits a quasi-stable global equilibrium, one in which all three strains can persist with nearly constant global abundance (15) . Further effects of evolution were incorporated into the Czárán et al. model by allowing as many as 14 distinct systems of toxin production, sensitivity, and resistance, along with the genetic processes of mutation and recombination that can alter these traits and their associations (15) . The permutations of these systems permit the existence of several million different strains. From this additional complexity emerges two distinct quasi-equilibrium conditions, the "frozen" and "hyper-immunity" states. In the frozen state, all the toxins are maintained globally, but most colonies are single-toxin producers. That is, each colony produces one toxin to which it is also immune. By contrast, in the hyper-immunity state, many colonies produce no toxin, many others make one, still others produce several toxins, but only a few produce most of the available toxins. Resistance shows a different distribution, with all of the colonies being resistant to most or all of the toxins. Which of these two outcomes is obtained depends upon initial conditions. If the evolving system begins with the entire population sensitive to all toxins, then the frozen state results. The hyper-immunity state is reached if the system starts with enough diversity that most colonies already have multiple killer and resistance traits.
Numerous surveys of colicin production in natural populations suggest that populations of E. coli may closely match predictions of the Czárán model (29, 72) . In E. coli, producer strains are found in frequencies ranging from 10% to 50%. Resistant strains are even more abundant and are found at frequencies from 50% to 98%. In fact, most strains are resistant to all co-segregating colicins. Finally, there is a small population of sensitive cells. Figure 5 provides a summary of phenotype distributions in a population of E. coli isolated from wild field mice in Australia (29) . The Czárán model predicts this distribution of phenotypes results from frequent horizontal transfer of resistance, and the significant cost to colicin production (15) . In other words, if a strain can gain resistance and lose production, it will over time-just as was observed in the E. coli isolated from the field mouse population over the course of a summer (29) . 
The Killing Breadth of Bacteriocins
We assume bacteriocins play a role in mediating within-species (or populationlevel) dynamics. This assumption is based upon the narrow killing range exhibited by most bacteriocins. However, recent work calls this assumption into question. Bacteriocins from natural isolates of several species of enteric bacteria were assayed for their killing effect against a large set of nonproducers isolated from the same sources (M.A. Riley, C.M. Goldstone, J.E. Wertz & D. Gordon, unpublished information). Figure 6 reveals that contrary to expectations killing breadth varies significantly for different bacteriocins. Some are clearly most effective at killing within the producer strains own species. Others kill more broadly or kill quite specifically isolates of a different species. This diversity of killing breadth argues that bacteriocins, contrary to prior suggestions, play an equally compelling role in mediating both population-level and community-level interactions. A more Figure 6 Phylogenetic breadth of bacteriocin killing. The killing spectrum of each class of bacteriocins was cross-referenced with a phylogenetic tree of the enteric species they were screened against. Heights of the black boxes are proportional to the percentage of strains sensitive to each class of bacteriocin. Bacteriocins were screened against 40 natural isolates from each enteric species. The molecular phylogeny of a subset of enteric bacteria is based on a composite of five housekeeping genes (gapA, groEL, gyrA, ompA, pgi) and 16s ribosomal sequences. The tree is rooted using Vibrio cholerae as an outgroup. KO, Klebsiella oxytoca; KP, Klebsiella pneumoniae; EB, Enterobacter cloacae; CF, Citrobacter freundii; EC, E. coli; SM, Serratia marcescens; HA, Hafnia alvei; VC, Vibrio cholerae. thorough understanding of how bacteriocins function awaits the development of a more biologically realistic experimental approach. Prior studies have considered how producer, sensitive, and resistant strains within the same species interact. If the goal is to understand the role these toxins play in nature, our experiments must incorporate more complex microbial communities and environments.
BACTERIOCIN APPLICATIONS
Bacteriocins and Human Health
The rapid rise and spread of multi-resistant bacterial pathogens have forced the consideration of alternative methods of combating infection (59, 78) . One of the limitations of using broad-spectrum antibiotics is that they kill almost any bacterial species not specifically resistant to the drug. Given such a broad killing spectrum, these antibiotics are used frequently, which results in an intensive selection pressure for the evolution of antibiotic resistance in both pathogen and commensal bacteria (100) . Once resistance appears, it is simply a matter of time and the intensity of human-mediated selection before human pathogens will acquire resistance (54) .
Current solutions to this dilemma involve developing a more rationale approach to antibiotic use, which involves curtailing the prescription of drugs for anything other than bacterial infections, cycling through different drugs over a shorter time frame, and educating the public about the necessity of taking an entire course of antibiotics (54, 89) . Bacteriocins provide an alternative solution. With their relatively narrow spectrum of killing activity, they can be considered "designer drugs," which target specific bacterial pathogens. Given the diversity of bacteriocins produced in nature, it is a relatively simple task to find bacteriocins active against specific human pathogens (R.L. Dorit & M.A. Riley, unpublished information). The development and use of such narrow-spectrum antimicrobials not only increases the number of drugs on the pharmaceutical shelf but, more importantly, extends their shelf life. This latter feature emerges because with a designer drug approach, each antibiotic is used infrequently, which results in a reduction in the intensity of selection for resistance. From an ecological and evolutionary perspective, the use of narrow-spectrum antimicrobials to address the current threat posed by multi-resistance bacterial pathogens makes quite a bit of sense. It leads to a reduction in the collateral killing of nonpathogen species, i.e., commensal species, which in turn leads to a decrease in nosocomial infection levels. It also results in a reduction in the intensity of selection for antibiotic resistance. With so few species of bacteria killed by each designer drug, antibiotic resistance resulting from antibiotic use will evolve and spread more slowly.
Bacteriocins and Food Preservation
The only bacteriocins currently employed in food preservation are those produced by LAB used in the production of fermented foods (56) . Because LAB have been used for centuries to ferment foods, they enjoy GRAS (generally regarded as safe) status by the U.S. Food and Drug Administration (FDA). This permits their use in fermented foods without additional regulatory approval (56) .
Nisin was the first bacteriocin to be isolated and approved for use in foods, specifically to prevent the outgrowth of Clostridium botulinum spores in cheese spreads in England (12) . By 1988, the FDA had approved its use as a biopreservative for a narrow range of foods, including pasteurized egg products. Today, nisin is accepted as a safe food preservative by over 45 countries, and it is the most widely used commercial bacteriocin and it remains the only bacteriocin that may be added to U.S. foods.
Over the past decade the recurrence of listeriosis outbreaks, combined with the natural resistance of the causative agent, Listeria monocytogenes, to traditional food preservation methods such as its ability to grow at near-freezing temperatures has focused the attention of bacteriocin researchers on this organism (61) . This attention has resulted in the isolation of a large number of class IIa bacteriocins, all of which are highly active against L. monocytogenes [recently reviewed in (23)].
The next wave of development of bacteriocins as food preservatives is at hand. Bacteriocins have been discovered in cured meats, milk and cheese, spoiled salad dressing, and soybean paste. Luchansky and colleagues have developed a gelatin form of pediocin, a class IIa bacteriocin made by lactic acid-producing bacteria, that protects hot dogs from Listeria contamination (67) . His team has also added a strain of pediocin-producing bacteria to sausage and found a reduction of Listeria numbers to be fewer than one ten-thousandth the original number in untreated sausage. Equally compelling, active pediocin was found in the sausage after two months of refrigeration. At the University of Melbourne in Australia, Barrie Davidson has been targeting Listeria with piscicolin, a bacteriocin from yet another lactic acid-producing bacterium (67) . Piscicolin has already been patented and it will soon be ready for use in meat products and as a rinse for salad greens or chicken parts (67) .
A natural concern about using bacteriocins for the preservation of food is the selection of resistant strains. Studies in LAB have shown that resistance carries a significant fitness cost, with resistant strains having a slower growth rate than their sensitive ancestor (19) . Treatment with a combination of bacteriocins, for instance nisin and a class IIa bacteriocin, would theoretically reduce the incidence of resistance (5, 99). There is currently conflicting evidence as to whether resistance to one class of LAB bacteriocins can result in cross-resistance to another class (5, 88) .
CONCLUSIONS AND FUTURE DIRECTIONS
Bacteriocins represent one of the best-studied microbial defense systems. Although we are still in the earliest stages of exploring their evolutionary relationships and ecological roles, it is clear from their abundance and diversity that they are the microbial weapons of choice. Sorting out why they are such a successful family of toxins will require a substantial commitment to future research. Answering this question will require a substantial effort to more fully characterize the diversity of bacteriocin proteins, their modes of targeting and killing, the gene clusters that encode them, and the mechanisms of bacteriocin gene regulation. In addition, we require more sophisticated ecological models (both empirical and theoretical) to aid in our growing sense of the diverse roles the toxins play in mediating microbial dynamics and maintaining microbial diversity. The impact of such studies is not solely academic. The potential for bacteriocins to serve as alternatives to classical antibiotics in treating bacterial infections is real, and the application of bacteriocins in food preservation is exploding. The future roles bacteriocins may serve is limited only by our imagination.
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